Background: It has been reported that poststroke pain has a complex pharmacologic background and that only about one-half of poststroke pain patients are sensitive to motor cortex stimulation induced by repetitive transcranial magnetic stimulation (rTMS).
Objectives: The relationship between pharmacologic background and effects of rTMS of the primary motor cortex was investigated to clarify the pharmacologic basis of rTMS-induced analgesia in poststroke pain patients.
Methods: Changes in visual analog scale (VAS) score for pain following drug challenge tests using ketamine, morphine, and thiopental were compared with the changes in VAS score following rTMS of the primary motor cortex (frequency 5 Hz, at 100% resting motor threshold, 500 pulses per session) in 20 poststroke pain patients.
Results: In our drug challenge test, 10 of 20 (50%) patients in ketamine test, 7 of 20 (35%) in thiopental test, and 3 of 20 (15%) in morphine test showed more than 40% reduction of VAS score. VAS score decreased immediately after rTMS of motor cortex and persisted for 300 min (p < 0.05, Bonferroni's multiple comparisons). Comparison of the magnitude of VAS score reduction between drug challenge test and rTMS showed significant correlations with ketamine test (r = 0.503, p = 0.012), morphine test (r = 0.526, p = 0.009), and thiopental test (r = 0.609, p = 0.002) by regression analysis.
Conclusions: rTMS-induced VAS score reduction correlated well with morphine, ketamine, and thiopental tests. However, ketamine sensitivity was observed in more cases compared with morphine and thiopental in poststroke pain patients. We speculate that additional pharmacologic therapy using ketamine as determined on the basis of the ketamine test may be useful for enhancing the efficacy of rTMS in poststroke pain patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ner.12019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Comorbid anxiety disorders in patients with neurological pathology: current state of the problem and the role of etifoxine in treatment strategy].
Zh Nevrol Psikhiatr Im S S Korsakova
December 2024
Siberian State Medical University, Tomsk, Russia.
The article presents theses of the resolution of the Interdisciplinary Council of Experts in Psychiatry and Neurology (Moscow, 2024) on the issue of comorbid anxiety disorders (AD) in patients with neurological pathologies. The authors highlight the high prevalence of comorbid ADs and their significant negative impact on the course of underlying diseases, such as epilepsy, pain syndromes and post-stroke conditions. Modern approaches to the diagnosis and treatment of ADs in this group of patients are discussed.
View Article and Find Full Text PDFPrediction of Central Post-Stroke Pain by Quantitative Sensory Testing.
Ann Neurol
December 2024
Department of Neurology, Jewish Hospital Berlin, Berlin, Germany.
Objective: Among patients with acute stroke, we aimed to identify those who will later develop central post-stroke pain (CPSP) versus those who will not (non-pain sensory stroke [NPSS]) by assessing potential differences in somatosensory profile patterns and evaluating their potential as predictors of CPSP.
Methods: In a prospective longitudinal study on 75 acute stroke patients with somatosensory symptoms, we performed quantitative somatosensory testing (QST) in the acute/subacute phase (within 10 days) and on follow-up visits for 12 months. Based on previous QST studies, we hypothesized that QST values of cold detection threshold (CDT) and dynamic mechanical allodynia (DMA) would differ between CPSP and NPSS patients before the onset of pain.
Fatigue After Stroke Educational Recovery Program: A Prospective, Phase III, Randomized Controlled Trial.
J Am Heart Assoc
December 2024
National Institute for Stroke and Applied Neurosciences, School of Clinical Sciences Auckland University of Technology Auckland New Zealand.
Background: Poststroke fatigue affects ≈50% of patients with stroke, causing significant personal, societal, and economic burden. In the FASTER (Fatigue After Stroke Educational Recovery) study, we assessed a group-based educational intervention for poststroke fatigue.
Methods And Results: Two hundred patients with clinically significant fatigue were included and randomized to either a general stroke education control or fatigue management group (FMG) intervention and assessed at baseline, 6 weeks, and 3 months.
Progress of research into microglial mediation of central post-stroke pain.
Int J Immunopathol Pharmacol
December 2024
Department of Neurology & Psychology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong.
Central post-stroke pain (CPSP) is a chronic neuropathic pain syndrome that commonly occurs after cerebral stroke, and it severely impairs the daily activities of stroke patients. A number of fundamental and clinical studies support the theory that CPSP is mainly caused by ischemic and hemorrhagic injury of the spinal-thalamic-cortical neural pathway. However, the underlying reasons of CPSP genesis and development are far from clear.
View Article and Find Full Text PDFA scoping review of mind-body therapies for people with persistent pain after stroke.
Disabil Rehabil
December 2024
School of Allied Health, Human Services and Sport, La Trobe University, Melbourne, Australia.
Purpose: Persistent pain post-stroke is common; however, non-medical management options remain under-researched. This scoping review sought to identify and summarise existing literature regarding mind-body therapies for people with persistent pain post-stroke, examine pain and pain-related biopsychosocial outcomes, and identify areas for future research.
Materials And Methods: This review followed PRISMA and JBI guidelines; the protocol was registered on Open Science Framework.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!